Furfuryl alcohol-based resins are commonly used as binding agents in foundry sand-moulds and as a corrosion inhibitor in mortar, grout, and cement. When mixed with foundry sand and exposed to heat or acid catalysts furfuryl alcohol initiates polymerization or "curing" of the sand. As the curing proceeds, it causes the sand to become dimensionally stable and furfuryl alcohol is vaporized. Furfuryl alcohol is considered by the EPA to be a high volume production chemical with over 1 million pounds produced annually in the United States. This coupled with numerous uses provide considerable potential for exposure of workers and the general public to furfuryl alcohol and furfuryl alcohol-based resins. The potential for exposure to furfuryl alcohol exists though pulmonary, oral, and dermal routes of exposure. It has been reported to be highly toxic in laboratory animals with exposure to higher concentrations producing signs of central nervous system depression, such as headache, drowsiness, nausea and vomiting. Although furfuryl alcohol was nominated and evaluated for carcinogencity potential by the NTP, studies evaluating immunotoxicity are lacking. Limited human exposure data reports a higher incidence of asthma in foundry mold workers exposed to furan resin, suggesting a potential immunological effect. These studies were executed to evaluate the immunotoxic potential of furfuryl alcohol following exposure including the dermal route. Furfuryl alcohol was tested in a combined irritancy local lymph node assay (LLNA) that also examined irritancy. It was identified to be an irritant at high concentrations and a sensitizer with an EC3 value of 25.6% resulting in classification as a mild sensitizer. Significant increases were observed in the B220+ and IgE+B220+ cell populations in the draining lymph nodes after exposure to furfuryl concentrations of 25% and 75% respectively. No elevation in total serum IgE levels were observed after exposure to any concentration of furfuryl alcohol. These results suggest that furfuryl alcohol may function as a T-cell mediated sensitizer.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.
CDC.gov Privacy Settings
We take your privacy seriously. You can review and change the way we collect information below.
These cookies allow us to count visits and traffic sources so we can measure and improve the performance of our site. They help us to know which pages are the most and least popular and see how visitors move around the site. All information these cookies collect is aggregated and therefore anonymous. If you do not allow these cookies we will not know when you have visited our site, and will not be able to monitor its performance.
Cookies used to make website functionality more relevant to you. These cookies perform functions like remembering presentation options or choices and, in some cases, delivery of web content that based on self-identified area of interests.
Cookies used to track the effectiveness of CDC public health campaigns through clickthrough data.
Cookies used to enable you to share pages and content that you find interesting on CDC.gov through third party social networking and other websites. These cookies may also be used for advertising purposes by these third parties.
Thank you for taking the time to confirm your preferences. If you need to go back and make any changes, you can always do so by going to our Privacy Policy page.